Abstract
Correlation of flow cytometric measurable residual disease (FC-MRD) with molecular MRD and clinical outcome at one year in adult B-acute lymphoblastic leukaemia (B-ALL) and acute myeloid leukaemia (AML)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
